Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open randomized phase II study of darbepoetin alfa for anemia in patients with hormone-refractory prostate cancer treated with Taxotere
2007-007137-38Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Feb 2008
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of darbepoetin alfa in anaemia (2 arms), sponsored by Vejle Hospital. Primary endpoints: Hemoglobin level over time and Red blood cell transfusion requirement. Started Feb 2008; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anaemia
Beyond the preview
Go deeper on 2007-007137-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007137-38.